M
Mauricio Tohen
Researcher at University of New Mexico
Publications - 476
Citations - 34199
Mauricio Tohen is an academic researcher from University of New Mexico. The author has contributed to research in topics: Bipolar disorder & Olanzapine. The author has an hindex of 95, co-authored 464 publications receiving 32214 citations. Previous affiliations of Mauricio Tohen include University of Minnesota & University of Alabama at Birmingham.
Papers
More filters
Journal ArticleDOI
Practice guideline for the treatment of patients with schizophrenia
Marvin I. Herz,Robert Paul Liberman,T. H. McGlashan,Jeffrey A. Lieberman,Richard Jed Wyatt,Stephen R. Marder,P. Wang,C. Allgulander,Ross J. Baldessarini,R. Balon,A. S. Bellack,C M Jr Berlin,C. H. Blackington,Peter F. Buckley,D. G. Carlson,J. Cott,Francine Cournos,P. Desai,L. Dickstein,Wayne Fenton,W. A. Fisher,Lois T. Flaherty,R. Freedman,Marc Galanter,E. Galton,Rohan Ganguli,L. K. Garrettson,S. Goldfinger,L. S. Goldman,M. Z. Goldstein,T. R. Gordy,S. H. Gray,Monica R. Green,W. M. Greenberg,John G. Gunderson,L. L. Hall,E. Haller,E. Hanin,L. Hawkins,T. W. Hester,T. Horn,J. K. Hsiao,N. V. Juthani,John M. Kane,A. Kayser,H. D. Kibel,R. A. Kimmich,R. R. Koegler,J. Krajeski,T. Kuehnel,J.S. Lamberti,Anthony F. Lehman,J. Leunello,R. L. Martin,R. McCarley,Mark McGee,Herbert Y. Meltzer,M.-Marsel Mesulam,Jeffrey L. Metzner,Loren R. Mosher,J. A. Motto,Kim T. Mueser,R. A. Munoz,H. A. Nasrallah,J. W. Newcomer,Lewis A. Opler,G. N. Peterson,M. Rapaport,Michelle Riba,V. I. Rickert,A. Rifkin,J. S. Rivenbark,S. Robertson,P. Ruiz,W. G. Ryan,M. O. Sanderson,R. B. Schiffer,P. M. Schyve,R. H. Sebring,W. W. Shen,D. Shore,G. M. Simpson,H. E. Soufi,L. I. Stein,N. Stotland,J. Strauss,D. Sundberg,D. Svendsen,Mauricio Tohen,M. Tsuang,J. G. Wagnitz,Richard D. Weiner,W. D. Weitzel,L. J. Wilkerson,D. Wingerson,C A Jr Zarate,J. Zito,Howard Zonana +97 more
Journal ArticleDOI
Efficacy of Olanzapine and Olanzapine-Fluoxetine Combination in the Treatment of Bipolar I Depression
Mauricio Tohen,Mauricio Tohen,Eduard Vieta,Joseph R. Calabrese,Terence A. Ketter,Gary S. Sachs,Charles L. Bowden,Philip B. Mitchell,Franca Centorrino,R.C. Risser,Robert W. Baker,Angela R. Evans,Karin Beymer,Sanjay Dubé,Sanjay Dubé,Gary D. Tollefson,Alan Breier +16 more
TL;DR: Olanzapine is more effective than placebo, and combined olanzapine-fluoxetine isMore effective than olanZapine and placebo in the treatment of bipolar I depression without increased risk of developing manic symptoms.
Journal ArticleDOI
Antipsychotic drug effects on brain morphology in first-episode psychosis
Jeffrey A. Lieberman,Jeffrey A. Lieberman,Gary D. Tollefson,Cecil Charles,Robert B. Zipursky,Tonmoy Sharma,René S. Kahn,Richard S.E. Keefe,Alan I. Green,Raquel E. Gur,Joseph P. McEvoy,Diana O. Perkins,Robert M. Hamer,Hongbin Gu,Mauricio Tohen,Mauricio Tohen +15 more
TL;DR: In this article, the authors found that olanzapine-treated patients have less change over time in whole brain gray matter volumes and lateral ventricle volumes than haloperidol-treatment patients and that gray matter changes are associated with changes in psychopathology and neurocognition.
Journal ArticleDOI
One hundred years of schizophrenia: a meta-analysis of the outcome literature.
TL;DR: Overall, less than half of patients diagnosed with schizophrenia have shown substantial clinical improvement after follow-up averaging nearly 6 years, despite considerable gains in improvement rates after mid-century, there has been a decline since the 1970s.
Journal ArticleDOI
Efficacy of olanzapine in acute bipolar mania: A double-blind, placebo-controlled study
Mauricio Tohen,T. Jacobs,S. L. Grundy,Susan L. McElroy,Michael C. Banov,Philip G. Janicak,Todd M. Sanger,R.C. Risser,Fan Zhang,V. Toma,Judith Francis,Gary D. Tollefson,Alan Breier +12 more
TL;DR: Olanzapine demonstrated greater efficacy than placebo in the treatment of acute bipolar mania and was generally well tolerated.